Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
20.07.2025 10:48:00
|
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged a pair of pre-revenue businesses with price targets that are miles above their current stock prices.Compass Pathways (NASDAQ: CMPS) is developing a depression treatment based on a recreational drug that produced some interesting results in a clinical trial. Viking Therapeutics (NASDAQ: VKTX) is developing anti-obesity treatments that could compete toe-to-toe with blockbusters like Wegovy and Zepbound.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool